Interview

#Career #Cell Science #Interview #Meet the Researcher #University of Glasgow

Meet the researcher: Elaine Duncan, University of Glasgow

DDW’s Diana Spencer speaks to Elaine Duncan, a PhD student on the lifETIME (Engineered Tissues for Discovery, Industry and Medicine) CDT at the University of Glasgow. DS: Can you tell us what you do and what you’re working on at the moment? ED: I’m currently a… Read More

#Exclusive Content

MRI of the brain
#AI / data analytics / healthtech / informatics #epilepsy #Interview #Omics #Sitting Down With

Sitting down with… Stefanie Dedeurwaerdere, UCB

Stefanie Dedeurwaerdere is Global Strategy Lead for Pipeline Development in Global Epilepsy & Rare Syndromes at UCB. In her day-to-day role, she is responsible for the development of UCB’s epilepsy discovery strategy, working with researchers to advance understanding of epilepsies while ensuring candidates for a future clinical… Read More

#Exclusive Content #Opinion

#3D chemistry #AI #Artificial intelligence (AI) #Biologics #Biotechnology #Cell and gene therapy #Contract development and manufacturing organisations #Covid-19 #Gene expression #Gene mutation #Interview #mRNA #Next generation sequencing #Oncology #PharmEnable #RNA sequencing #Single-cell RNA sequencing #Vaccines

Podcast: What trends will speed up the journey from clinic to bedside?

This is the latest episode of the free DDW narrated podcast, titled “What trends will speed up the journey from clinic to bedside?” which covers three written for Volume 23 – Issue 4, Fall 2022 of DDW. They are called: Sitting down with… PharmEnable, Is single-cell… Read More

#News

#AI / data analytics / healthtech / informatics #Human disease models #Interview #Neurology #Neuroscience #Stem cells

Putting human data at the centre of drug discovery

Listen to this article on the DDW Podcast: James Peach is the Co-Founder and CEO of Human Centric Drug Discovery (HCDD), an Oxford University spin-out improving neurology drug discovery by bringing more human data to the process. Peach shared his insight with DDW’s Megan Thomas. MT: In… Read More

#Exclusive Content #Opinion

Cells under a microscope
#bit bio #CAR-T #Cell therapy #Interview #iPSC #Stem cells

Scaling up: The need for human cells to give better access to cell therapies

Reece Armstrong speaks to Kathryn Golden, SVP Technical Operations and Manufacturing, bit.bio, about novel technologies, and methods to manufacture human cells for therapies so more patients can access these treatments. Cell therapies have emerged as transformative and potentially curative treatments across a range of disease… Read More

#Exclusive Content

#Cancer research #Career #Harvard Medical School #Interview #Meet the Researcher #Oncology

Meet the researcher: Jenny Hogstrom-Stakem

Jenny Hogstrom-Stakem, Postdoctoral Research Fellow, was recently awarded the 2023 AACR-AstraZeneca Breast Cancer Research Fellowship. Here she shares her career highlights and advice with DDW’s Diana Spencer. DS: Can you tell us what you do and what you’re working on at the moment? JHS:… Read More

#Exclusive Content

#Career #Interview #Meet the Researcher #Nanomedicine / nanotechnology #University of Oxford

Meet the researcher: Molly Stevens, Oxford University and Imperial

Listen to this article on the DDW Podcast: Megan Thomas talks to Molly Stevens, John Black Professor at Oxford University and Research Director for Biomedical Materials at Imperial College London. MT: Where do you work, and can you tell us what you’re working on at the moment?… Read More

#Exclusive Content

#Antibodies #Career #From the top #Interview #Women in STEM

From the Top: Adele Hannigan, Antibody Analytics

Listen to this article on the DDW Podcast: Megan Thomas shines a spotlight on Adele Hannigan, CBO for Antibody Analytics. She outlines how her interest in immunotherapy began and what keeps it alive today. MT: What has you career path looked like? Were there any… Read More

#Exclusive Content

Magnifying glass
#Career #From the top #Interview #Medicines Discovery Catapult

From the top: Dr Martin Main, Medicines Discovery Catapult

Listen to this article on the DDW Podcast: Megan Thomas speaks to Dr Martin Main, Chief Scientific Officer, Medicines Discovery Catapult. MT: What do you do, and how did you get here?  MM: I am Chief Scientific Officer (CSO) at Medicines Discovery Catapult (MDC). MDC… Read More

#Exclusive Content

#Drug discovery #Interview #Next generation sequencing #NGS #Personalised medicine

The use-case for NGS

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Dr Darrell Green, Lecturer in RNA Biology, Biomedical Research Centre, Norwich Medical School University of East Anglia, about his work using next generation sequencing (NGS) and the areas the technology is… Read More

#Exclusive Content

#Carbon emissions #Environmental impact #Green lab movement #Interview #Lab technology #Sustain

The considerations for building sustainable labs in pharma

Listen to this article on the DDW Podcast: DDW Editor Reece Armstrong speaks to Will Fogden, UK Development Manager, Kadans Science Partner, about sustainable efforts in pharma and the considerations industry needs to take into account when developing sustainable buildings. RA: We’ve seen large-scale sustainability… Read More

#Exclusive Content #Trends & Analysis

#Career #Interview #Meet the Researcher #Research and development

Meet the researcher: Giusy Di Conza, iOnctura

Listen to this article on the DDW Podcast: DDW’s Megan Thomas looks at a day in the life of Giusy Di Conza, Head of Research at iOnctura. MT: Where do you work, and can you tell us what you’re working on at the moment?… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Cancer research #Genetics / genomics #Interview #Oncology #Sitting Down With

Sitting down with… Neil Dhawan

Listen to this article on the DDW Podcast: Reece Armstrong speaks to Neil Dhawan, the Co-founder and CEO of Totus Medicines about the company’s approach to drug discovery using fundamental technologies in chemistry, biology and artificial intelligence (AI). RA: How is Totus Medicines attempting to… Read More

#Cancer Research #Exclusive Content

#ApconiX #Biosafety testing #Drug safety #Interview #Podcast #Sitting Down With podcast

What are the benefits of a target safety assessment?

In a DDW Sitting Down With podcast with Lu Rahman, Ruth Roberts and Claire Sadler, ApconiX, discuss the benefits of performing a target safety assessment (TSA) during drug discovery and development when a biological target is going to be acted on by a drug. The… Read More

#Exclusive Content